Synthetic biology redirects oncogenic signaling against cancer

How a synthetic biology system from Stanford turns EGF receptor signaling against cancer

Stanford scientists have used synthetic biology to turn cancer cell signaling against tumors by harnessing EGF receptor signaling instead of inhibiting it, and might spin out a company to develop the technology.

The Stanford University team’s technology, dubbed Rewiring of Aberrant Signaling to Effector

Read the full 430 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers